PSEN1 G417S mutation in a Chinese pedigree causing early-onset parkinsonism with cognitive impairment

Neurobiol Aging. 2022 Jul:115:70-76. doi: 10.1016/j.neurobiolaging.2022.03.016. Epub 2022 Apr 11.

Abstract

Presenilin 1 (PSEN1) mutations are a major cause of familial Alzheimer's disease. The pathogenic variant, PSEN1 p.G417S, has been reported to be associated with spastic paraparesis and cotton wool plaques in Japan. Here, we report a 3 generation Chinese pedigree that included 10 patients presenting with early-onset and rapid progression of parkinsonism with cognitive impairment in their third or fourth decade of life. Three additional living patients developed different degrees of cognitive impairment, without movement disorders. Magnetic resonance imaging of the brain showed white matter hyperintensities, multiple microbleeds, and enlarged perivascular spaces. Whole exome sequencing analysis of the proband detected the mutation, p.G417S, in PSEN1, which was completely co-segregated with the disease phenotype within the family by Sanger sequencing. 3D protein structures predicted that the mutation might influence contact with the lipid membrane and the interaction with beta-catenin. Our study provides insights into the heterogeneity in clinical presentation and imaging associated with mutations in PSEN1.

Keywords: Alzheimer's disease; Cognitive impairment; PSEN1; Parkinsonism; Whole exome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / genetics
  • Alzheimer Disease* / metabolism
  • China
  • Cognitive Dysfunction* / genetics
  • Humans
  • Mutation / genetics
  • Parkinsonian Disorders* / complications
  • Parkinsonian Disorders* / diagnostic imaging
  • Parkinsonian Disorders* / genetics
  • Pedigree
  • Presenilin-1 / genetics

Substances

  • PSEN1 protein, human
  • Presenilin-1